We are proud to announce that Roche, one of the world’s most innovative pharmaceutical and diagnostics companies, has officially joined the Swiss Iraqi Business Association (SIBA).
Headquartered in Basel, Switzerland, Roche is globally recognized for its leadership in oncology, immunology, and personalized healthcare. With over a century of scientific excellence and a strong commitment to research and development, Roche continues to shape the future of medicine. Its membership in SIBA reflects a shared vision to promote Swiss–Iraqi collaboration in healthcare, biotechnology, and sustainable development. As Iraq works toward enhancing its healthcare system and infrastructure, Roche’s expertise will be instrumental in creating opportunities for knowledge exchange, innovation, and impactful partnerships. We warmly welcome Roche to SIBA and look forward to advancing meaningful dialogue and collaboration between Switzerland and Iraq in the healthcare sector.
Roche’s expertise in pharmaceuticals and diagnostics, paired with its commitment to innovation, offers immense value to SIBA’s mission of strengthening Swiss–Iraqi collaboration:
- Healthcare Innovation: Roche brings cutting-edge advances in oncology, immunology, diagnostics, and personalized medicine to the SIBA network—areas vital to Iraq’s healthcare development.
- Strategic R&D Presence: With premier research centers in Basel and Zurich dedicated to breakthroughs in immunotherapy and oncology, Roche reinforces the potential for Swiss–Iraqi R&D partnerships.
- Global Influence, Local Impact: Leveraging its deep local roots and global scale, Roche is well-positioned to inspire impactful collaborations in healthcare and education across the SIBA platform.
Welcome to SIBA, Roche! We look forward to building bridges in healthcare innovation, knowledge exchange, and sustainable growth.
